-
Entity
-
Individual
-
Location
-
87 Cambridgepark Drive, C/O Ra Pharmaceuticals, Inc., Cambridge, MA
-
Summary
-
The estimated net worth of Douglas A. Treco is at least $349K dollars as of October 3, 2024. Douglas A. Treco is the CEO, Director of Inozyme Pharma, Inc. and owns shares of Inozyme Pharma, Inc. (INZY) stock worth about $349K.